The study not only displays the association of AID and DNMT1 and identifies a novel biological function of AID, but also provides novel information regarding the use of DNMT inhibitors to treat AID-positive hematopoietic cancers. This evidence concerns the gene AICDA and hematopoietic and lymphoid cell neoplasm.